1. Nischal KC, Böer A. Understanding "livedo vasculitis": Part I—A glossary, in historical perspective, of terms related to "livedo" and "livedo vasculitis" Dermatopathol: Prac & Conc. 2005;11(3):4.

2. Nischal KC, Böer A. Understanding "livedo vasculitis": Part II—Findings morphologic in livedo vasculitis. Dermatopathol: Prac & Conc. 2006;12(1):4.

3. Milian G. Les atrophies cutanées syphilitques. Bull Soc Fr Dermatol Syphiliol. 1929;36:865.

4. Gougerot H, Jacob L, Hamburger J. Capillariate télangiectasique et atrophicante (Atrophie blanche). Bull Soc Fr Dermatol Syphiligr. 1936;43:1792-1794.

5. O'Leary PA, Montgomery H, Brunstig LA. Livedo reticluaris: recurring ulcerations of the ankles in the summer. Arch Dermatol. 1944;50:213-214.

6. O`Leary PA, Montgomery H, Brunstig LA, Kierland RR, Perry H. summer ulcerations with livedo reticularis. AMA Arch Dermat Syph. 1955;71:279.

7. Ellerbroek U. Capillaritis alba. Dermatologische Wochenschrift 1953;49:1208.

8. Nelson LM. Atrophie blanche en plaque. AMA Arch Derm. 1955;72:242-251.   

9. Feldaker M, Hines EA Jr, Kierland RR. Livedo reticularis with summer ulcerations. AMA Arch Derm. 1955;72:31-42.   

10. Feldaker M, Hines EA Jr, Kierland RR. Livedo reticularis with ulcerations. Circulation 1956;13:196-216.   

11. Schuppener HJ. Zur Kenntnis der Atrophia alba (Atrophie blanche Milian). Arch Klin Exp Dermatol. 1957;204:500-522.   

12. Gray HR, Graham JH, Johnson W, Burgoon CF Jr. Atrophie blanche: periodic painful ulcers of lower extremities: a clinical and histopathological entity. Arch Dermatol. 1966;93:187-193.   

13. Bard JW, Winkelmann RK. Livedo vasculitis: Segmental hyalinizing vasculitis of the dermis. Arch Dermatol. 1967;96:489-499.   

14. Winkelmann RK, Schroeter AL, Kierland RR, Ryan TM. Clinical studies of livedoid vasculitis: (segmental hyalinizing vasculitis). Mayo Clin Proc. 1974;49:746-750.   

15. Gilliam JN, Herndon JH, Prystowsky SD. Fibrinolytic therapy for vasculitis of atrophie blanche. Arch Dermatol. 1974;109:664-667.   

16. Milstone LM, Braverman IM, Lucky P, Fleckman P. Classification and therapy of atrophie blanche. Arch Dermatol. 1983;119:963-969.   

17. McCalmont CS, McCalmont TH, Jorizzo JL, White WL, Leshin B, Rothberger H. Livedo vasculitis: vasculitis or thrombotic vasculopathy? Clin Exp Dermatol. 1992;17:4-8.   

18. Papi M, Didona B, De Pita O, Frezzolini A, Di Giulio S, De Matteis W et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Arch Dermatol. 1998;134:447-452.   

19. Gjessing HC, Dedichen J. Livedo reticularis with summer ulcerations; report of case treated with long-term anticoagulation therapy. Acta Med Scand. 1956;156(Suppl 319):74-78.   

20. Schroeter AL, Diaz-Perez JL, Winkelmann RK, Jordan RE. Livedo vasculitis (the vasculitis of atrophie blanche): immunohistopathologic study. Arch Dermatol. 1975;111:188-193.   

21. Kern AB. Atrophie blanche. Report of two patients treated with aspirin and dipyridamole. J Am Acad Dermatol. 1982 Jun;6(6):1048-1053.

22. Drucker CR, Duncan WC. Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol. 1982 Sep;7(3):359-363.

23. Shornick JK, Nicholes BK, Bergstresser PR, Gilliam JN. Idiopathic atrophie blanche. J Am Acad Dermatol. 1983;8:792-798.   

24. Sams WM Jr. Livedo vasculitis. Therapy with pentoxifylline. Arch Dermatol. 1988 May;124(5):684-687.

25. Yamamoto M, Danno K, Shio H, Imamura S. Antithrombotic treatment in livedo vasculitis. J Am Acad Dermatol. 1988 Jan;18(1 Pt 1):57-62.

26. Rustin MH, Bunker CB, Dowd PM. Chronic leg ulceration with livedoid vasculitis, and response to oral ketanserin. Br J Dermatol. 1989 Jan;120(1):101-105.

27. Yang LJ, Chan HL, Chen SY, Kuan YZ, Chen MJ, Wang CN, Chen WJ, Kuo TT. Atrophie blanche: a clinicopathological study of 27 patients. Changgeng Yi Xue Za Zhi 1991 Dec;14(4):237-245.

28. Cooper D, Bolognia JL, Lin JT. Atrophie blanche in a patient with gamma heavy chain disease. Arch Dermatol. 1991;127:272-273.   

29. Baccard M, Vignon-Pennamen MD, Janier M, Scrobohaci ML, Dubertret L. Livedo vasculitis with Protein C system deficiency. Arch Dermatol. 1992 Oct;128(10):1410-1411.

30. Hoogenberg K, Tupker RA, van Essen LH, Smit AJ, Kallenberg CG. Successful treatment of ulcerating livedo reticularis with infusions of prostacyclin. Br J Dermatol. 1992 Jul;127(1):64-66.

31. Suarez SM, Paller AS. Atrophie blanche with onset in childhood. J Pediatr. 1993 Nov;123(5):753-755.

32. Murrell DF, Jensen J, O"Keefe EJ. Failure of livedoid vasculitis to respond to tissue plasminogen activator. Arch Dermatol. 1995 Feb;131(2):231-232.

33. Hsiao GH, Chiu HC. Livedoid vasculitis. Response to low-dose danazol. Arch Dermatol. 1996 Jul;132(7):749-751.

34. Tsutsui K, Shirasaki F, Takata M, Takehara K. Successful treatment of livedo vasculitis with beraprost sodium: a possible mechanism of thrombomodulin upregulation. Dermatology 1996;192(2):120-124.   

35. Acland KM, Darvay A, Wakelin SH, Russell-Jones R. Livedoid vasculitis: a manifestation of the antiphospholipid syndrome? Br J Dermatol. 1999 Jan;140(1):131-135.

36. Choi HJ, Hann SK. Livedo reticularis and livedoid vasculitis responding to PUVA therapy. J Am Acad Dermatol. 1999 Feb;40(2 Pt 1):204-207.

37. Boyvat A, Kundakci N, Babikir MO, Gurgey E. Livedoid vasculopathy associated with heterozygous protein C deficiency. Br J Dermatol. 2000 Oct;143(4):840-842.

38. Ravat FE, Evans AV, Russell-Jones R. Response of livedoid vasculitis to intravenous immunoglobulin. Br J Dermatol. 2002 Jul;147(1):166-169.

39. Hegemann B, Helmbold P, Marsch WC. Livedoid vasculitis with ulcerations: the role of antithrombin III deficiency and its therapeutic consequences. Arch Dermatol. 2002 Jun;138(6):841-842.

40. Calamia KT, Balabanova M, Perniciaro C, Walsh JS. Livedo (livedoid) vasculitis and the factor V Leiden mutation: additional evidence for abnormal coagulation. J Am Acad Dermatol. 2002 Jan;46(1):133-137.

41. Hairston BR, Davis MD, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. Arch Dermatol. 2003 Aug;139(8):987-990.

42. Yang CH, Ho HC, Chan YS, Liou LB, Hong HS, Yang LC. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen. Br J Dermatol. 2003 Sep;149(3):647-652.

43. Schanz S, Ulmer A, Fierlbeck G. Intravenous immunoglobulin in livedo vasculitis: a new treatment option? J Am Acad Dermatol. 2003 Sep;49(3):555-556.

44. Gibson GE, Li H, Pittelkow MR.Homocysteinemia and livedoid vasculitis. J Am Acad Dermatol. 1999;40(2 Pt 1):279-81

45. Sato-Matsumura KC, Matsumura T, Hayashi H, Atsumi T, Kobayashi H. Factor XII deficiency: a possible cause of livedo with ulceration? Br J Dermatol. 2000;143(4):897-9

46. Marzano AV, Vanotti M, Alessi E. Widespread livedoid vasculopathy. Acta Derm Venereol. 2003;83(6):457-60

47. Grasland A, Crickx B, Blanc M, Pouchot J, Vinceneux P. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies] Ann Med Interne (Paris). 2000;151(5):408-10.   

48. Biedermann T, Flaig MJ, Sander CA. Livedoid vasculopathy in a patient with factor V mutation (Leiden). J Cutan Pathol. 2000;27(8):410-2.   

49. Gotlib J, Kohler S, Reicherter P, Oro AE, Zehnder JL. Heterozygous prothrombin G20210A gene mutation in a patient with livedoid vasculitis. Arch Dermatol. 2003;139(8):1081-3.   

50. Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Arch Dermatol. 2006;142(1):75-8.   

51. Cocuroccia B, Tonanzi T, Menaguale G, Fazio M, Girolomoni G. Livedoid vasculopathy and skin ulcers in patients with inherited thrombophilia. Eur J Dermatol. 2002;12(4):360-3.   

52. Abraham Z, Rozenbaum M, Portnoy E, Rosner I. Severe livedo vasculitis treated with potassium iodide. Rheumatol Int. 2003;23(2):96-8.   

53. Lee SS, Ang P, Tan SH. Clinical profile and treatment outcome of livedoid vasculitis: a case series. Ann Acad Med Singapore. 2003;32(6):835-9.   

54. Bisalbutra P, Kullavanijaya P. Sulfasalazine in atrophie blanche. J Am Acad Dermatol. 1993;28(2 Pt 1):275-6.   

55. Murrell DF, Jensen J, O"Keefe EJ. Failure of livedoid vasculitis to respond to tissue plasminogen activator. Arch Dermatol. 1995;131(2):231-2.   

56. Delacretaz J. [Treatment of livedo vasculitis by perfusion of a 10% dextran hydrolysate] Dermatologica. 1980;161(2):142-3

57. Purcell SM, Hayes TJ. Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol. 1986;14(5 Pt 1):851-4.   

58. Ackerman AB, Böer A, Benin B, Gottlieb GJ. Histologic Diagnosis of Inflammatory Skin Diseases. An Algorithmic Method Based on Pattern Analysis. 3rd Edition. New York: Ardor Scribendi, Ltd., 2005.